• ACM Research Reports Second Quarter 2024 Results

    Source: Nasdaq GlobeNewswire / 07 Aug 2024 06:00:00   America/New_York

    FREMONT, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its second quarter ended June 30, 2024.

    "I am pleased with our second quarter results. We delivered record revenue, strong profitability and positive cash flow from operations,” said ACM’s President and Chief Executive Officer, Dr. David Wang. “We are benefiting from continued investments by our customers, and market share gains from our existing and new products. I am also thrilled to announce today our new Panel Electrochemical Plating (Ultra ECP ap-p) tool, which we believe positions ACM to participate in the growing demand for AI solutions. Our proprietary horizontal plating enables advanced packaging with sub-micron features on square panels, which is especially applicable to GPUs and high-density high bandwidth memory (HBM). We are also making good progress with our global development activities, and we recently entered into an agreement to purchase a R&D facility with a clean room in Oregon, to expand our U.S. footprint to help accelerate our new customer initiatives.”

    Dr. Wang continued, "We have raised our 2024 revenue outlook to reflect continued investments by our customers, market share gains, and strong product cycles for the second half of the year. We have also taken the opportunity to raise our long-term revenue target to $3 billion based on increased confidence in our new product cycles and our international opportunities.”

     Three Months Ended June 30,
     GAAP Non-GAAP(1)
      2024   2023   2024   2023 
     (dollars in thousands, except EPS)
    Revenue$202,480  $144,577  $202,480  $144,577 
    Gross margin 47.8%  47.5%  48.2%  47.6%
    Income from operations$37,593  $30,430  $51,935  $32,447 
    Net income attributable to ACM Research, Inc.$24,210  $26,825  $37,521  $31,297 
    Basic EPS$0.39  $0.45  $0.60  $0.52 
    Diluted EPS$0.35  $0.41  $0.55  $0.48 


     Six Months Ended June 30,
     GAAP Non-GAAP(1)
      2024   2023   2024   2023 
     (dollars in thousands, except EPS)
    Revenue$354,671  $218,833  $354,671  $218,833 
    Gross margin 49.6%  49.6%  50.0%  49.8%
    Income from operations$62,825  $39,292  $91,736  $43,377 
    Net income attributable to ACM Research, Inc.$41,643  $33,970  $72,118  $41,164 
    Basic EPS$0.67  $0.57  $1.17  $0.69 
    Diluted EPS$0.61  $0.52  $1.07  $0.63 


    (1)Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized gain (loss) on short-term investments.


    Outlook

    ACM is increasing its revenue guidance for fiscal year 2024 to a range of $695 million to $735 million from the prior range of $650 million to $725 million. This expectation is based on ACM management’s current assessment of the continuing impact from international trade policy, together with various expected spending scenarios of key customers, supply chain constraints, and the timing of acceptances for first tools under evaluation in the field, among other factors.

    Operating Highlights and Recent Announcements

    • Shipments. Total shipments in the second quarter of 2024 were $202.5 million, up 32% from the second quarter of 2023. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in future quarters.
    • Introduced New Panel ECP Plating Tool to Strengthen FOPLP Portfolio. ACM introduced its new Panel Electrochemical Plating (Ultra ECP ap-p) tool designed for fan-out panel-level packaging (FOPLP). This new tool employs a horizontal plating approach and integrates ACM’s proprietary multi-anode technology, achieving uniformity and precision across the entire panel.
    • Entered FOPLP Market with Introduction of Ultra C vac-p Flux Cleaning Tool for Chiplets. ACM announced the Ultra C vac-p flux cleaning tool for fan-out panel-level packaging (FOPLP). Utilizing vacuum technology, the new tool efficiently removes flux residues from chiplet structures. ACM also announced it received a purchase order from a new China semiconductor manufacturer which has been shipped to the customer’s facility in July.
    • Received Order from U.S.-based Foundry and Wafer-level packing (WLP) Customer for an advanced packaging tool to be delivered to their U.S. facility in the first half of 2025.
    • Entered Agreement to Purchase a Clean Room in Hillsboro Oregon. On July 30, 2024, ACM entered into an agreement to purchase a 39,500 square foot facility, including a 5,200 square foot functional clean room. This facility is intended to replace ACM’s current Oregon facility and further expand R&D and demonstration capability in the U.S. market. The purchase is scheduled to close in the fourth quarter of 2024.
    • New General Counsel and Vice President of Corporate Strategy. ACM announced the appointment of Howard Chen as General Counsel and Vice President of Corporate Strategy, effective July 1, 2024.

    Second Quarter 2024 Financial Summary

    Unless otherwise noted, the following figures refer to the second quarter of 2024 and comparisons are with the second quarter of 2023.

    • Revenue was $202.5 million, up 40%, reflecting higher sales of single wafer cleaning, Tahoe and semi-critical cleaning equipment and ECP (front-end and packaging), furnace and other technologies, partly offset by lower sales of advanced packaging (excluding ECP), services & spares.
    • Gross margin was 47.8% versus 47.5%. Non-GAAP gross margin, which excludes stock-based compensation, was 48.2%% versus 47.6%. Gross margin exceeded ACM’s long-term business model range of 40% to 45%. ACM expects gross margin to vary from period to period due to a variety of factors, such as product mix, currency impacts and sales volume.
    • Operating expenses were $59.2 million, an increase of 55%. Operating expenses as a percentage of revenue increased to 29.2% from 26.4%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $45.6 million, up 25.7%. Non-GAAP operating expenses as a percentage of revenue decreased to 22.5% from 25.1%.
    • Operating income was $37.6 million, compared to $30.4 million. Operating margin was 18.6% compared to 21.0%. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $51.9 million, compared to $32.4 million. Non-GAAP operating margin, which excludes stock-based compensation, was 25.6% compared to 22.4%.
    • Unrealized gain (loss) on short-term investments was $1.0 million, compared to $(2.5) million. Unrealized gain (loss) reflects the change in market value of the investments by ACM’s principal operating subsidiary, ACM Research (Shanghai), Inc., in short-term investments. The value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
    • Income tax expense was $9.3 million, compared to $7.6 million.
    • Net income attributable to ACM Research, Inc. was $24.2 million, compared to $26.8 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized gain on short-term investments, was $37.5 million, compared to $31.3 million.
    • Net income per diluted share attributable to ACM Research, Inc. was $0.35, compared to $0.41. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized gain on short-term investments, was $0.55, compared to $0.48.
    • Cash and cash equivalents, plus restricted cash and short-term and long-term time deposits were $366.8 million at June 30, 2024, compared to $288.3 million at March 31, 2024.

    Conference Call Details

    A conference call to discuss results will be held on Wednesday, August 7, 2024, at 8:00 a.m. Eastern Time (8:00 p.m. China Time). To join the conference call via telephone, participants must use the following link to complete an online registration process. Upon registering, each participant will receive email instructions to access the conference call, including dial-in information and a PIN number allowing access to the conference call. This pre-registration process is designed by the operator to reduce delays due to operator congestion when accessing the live call.

    Online Registration: https://register.vevent.com/register/BIcf4dbc584cf54892966d5353590ab648

    Participants who have not pre-registered may join the webcast by accessing the link at ir.acmrcsh.com/events.

    A live and archived webcast will be available on the Investors section of the ACM website at www.acmrcsh.com.

    Use of Non-GAAP Financial Measures

    ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc. and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted earnings per share exclude the effect of stock-based compensation and unrealized gain (loss) on short-term investments, which ACM also believes are not indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of GAAP to non-GAAP Financial Measures.”

    ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.

    While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.

    Forward-Looking Statements

    Certain statements contained in this press release are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “plans,” “expects,” “believes,” “anticipates,” “designed,” and similar words are intended to identify forward-looking statements. Forward-looking statements are based on ACM management’s current expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from those stated or implied by the forward-looking statements. A description of certain of these risks, uncertainties and other matters can be found in filings ACM makes with the U.S. Securities and Exchange Commission, all of which are available at www.sec.gov. Because forward-looking statements involve risks and uncertainties, actual results and events may differ materially from results and events currently expected by ACM. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations with regard to these forward-looking statements or the occurrence of unanticipated events.

    About ACM Research, Inc.

    ACM develops, manufactures and sells semiconductor process equipment for single-wafer or batch wet cleaning, electroplating, stress-free polishing, vertical furnace processes, Track and PECVD, which are critical to advanced semiconductor device manufacturing and wafer-level packaging. ACM is committed to delivering customized, high performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield.

    © ACM Research, Inc. ULTRA C and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, these trademarks appear in this press release without ™ symbols, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to the trademarks.

    For investor and media inquiries, please contact:

    In the United States:The Blueshirt Group
     Steven C. Pelayo, CFA
     (360)808-5154
     steven@blueshirtgroup.co
      
    In China:The Blueshirt Group Asia
     Gary Dvorchak, CFA
     +86 (138) 1079-1480
     gary@blueshirtgroup.co


    ACM RESEARCH, INC.
    Condensed Consolidated Balance Sheets

     June 30, 2024 December 31, 2023
     (Unaudited)  
     (In thousands, except for per share data)
    Assets   
    Current assets:   
    Cash and cash equivalents$324,031  $182,090 
    Restricted cash 881   1,083 
    Short-term time deposits 27,183   80,524 
    Short-term investment 19,597   21,312 
    Accounts receivable, net 293,499   283,186 
    Other receivables 53,694   40,065 
    Inventories, net 602,927   545,395 
    Advances to related party 2,756   2,432 
    Prepaid expenses 18,594   20,023 
    Total current assets 1,343,162   1,176,110 
    Property, plant and equipment, net 228,731   201,848 
    Land use right, net 8,225   8,367 
    Operating lease right-of-use assets, net 6,252   7,026 
    Intangible assets, net 2,836   2,538 
    Long-term time deposits 14,656   40,818 
    Deferred tax assets 20,898   20,271 
    Long-term investments 31,898   27,880 
    Other long-term assets 10,917   6,050 
    Total assets$1,667,575  $1,490,908 
    Liabilities and Equity   
    Current liabilities:   
    Short-term borrowings$54,439  $31,335 
    Current portion of long-term borrowings 19,671   6,783 
    Related party accounts payable 18,012   11,407 
    Accounts payable 142,418   141,814 
    Advances from customers 205,609   181,368 
    Deferred revenue 5,279   3,687 
    Income taxes payable 11,136   6,401 
    FIN-48 payable 12,093   12,149 
    Other payables and accrued expenses 114,940   102,951 
    Current portion of operating lease liability 2,573   2,764 
    Total current liabilities 586,170   500,659 
    Long-term borrowings 70,833   53,952 
    Long-term operating lease liability 3,679   4,262 
    Other long-term liabilities 5,505   5,873 
    Total liabilities 666,187   564,746 
    Commitments and contingencies    
    Equity:   
    Stockholders’ equity:   
    Class A Common stock 6   6 
    Class B Common stock 1   1 
    Additional paid-in capital 659,462   629,845 
    Retained earnings 198,470   156,827 
    Statutory surplus reserve 30,060   30,060 
    Accumulated other comprehensive loss (54,830)  (49,349)
    Total ACM Research, Inc. stockholders’ equity 833,169   767,390 
    Non-controlling interests 168,219   158,772 
    Total equity 1,001,388   926,162 
    Total liabilities and equity$1,667,575  $1,490,908 


    ACM RESEARCH, INC.
    Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

     Three Months Ended June 30, Six Months Ended June 30,
      2024   2023   2024   2023 
     (Unaudited)
     ( In thousands, except share and per share data)
    Revenue$202,480  $144,577  $354,671  $218,833 
    Cost of revenue 105,696   75,938   178,766   110,208 
    Gross profit 96,784   68,639   175,905   108,625 
    Operating expenses:       
    Sales and marketing 17,135   11,439   31,308   20,776 
    Research and development 25,968   20,064   49,886   34,093 
    General and administrative 16,088   6,706   31,886   14,464 
    Total operating expenses 59,191   38,209   113,080   69,333 
    Income from operations 37,593   30,430   62,825   39,292 
    Interest income 2,381   2,346   4,155   4,131 
    Interest expense (932)  (649)  (1,715)  (1,344)
    Realized gain from sale of short-term investments -   3,919   273   7,913 
    Unrealized gain (loss) on short-term investments 1,031   (2,455)  (1,564)  (3,109)
    Other income (expense), net 1,357   3,724   4,437   2,306 
    Gain (loss) from equity method investments (695)  3,920   (1,215)  3,888 
    Income before income taxes 40,735   41,235   67,196   53,077 
    Income tax expense (9,336)  (7,638)  (13,705)  (10,517)
    Net income 31,399   33,597   53,491   42,560 
    Less: Net income attributable to non-controlling interests 7,189   6,772   11,848   8,590 
    Net income attributable to ACM Research, Inc.$24,210  $26,825  $41,643  $33,970 
    Comprehensive income (loss):       
    Net income 31,399   33,597   53,491   42,560 
    Foreign currency translation adjustment, net of tax 116   (35,269)  (6,713)  (25,846)
    Comprehensive Income 31,515   (1,672)  46,778   16,714 
    Less: Comprehensive income attributable to non-controlling interests 7,210   652   10,616   4,114 
    Comprehensive income attributable to ACM Research, Inc.$24,305  $(2,324) $36,162  $12,600 
            
    Net income attributable to ACM Research, Inc. per common share:       
    Basic$0.39  $0.45  $0.67  $0.57 
    Diluted$0.35  $0.41  $0.61  $0.52 
            
    Weighted average common shares outstanding used in computing per share amounts:       
    Basic 62,178,369   59,898,149   61,772,776   59,817,903 
    Diluted 67,057,846   64,929,638   66,520,706   64,968,900 


    ACM RESEARCH, INC.
    Total Revenue by Product Category and by Region

     Three Months Ended June 30, Six Months Ended June 30,
      2024  2023  2024  2023
     (Unaudited)
     ($ in thousand)
    Single wafer cleaning, Tahoe and semi-critical cleaning equipment$153,221 $112,528 $262,691 $149,142
    ECP (front-end and packaging), furnace and other technologies 38,962  19,117  64,762  45,715
    Advanced packaging (excluding ECP), services & spares 10,297  12,932  27,218  23,976
    Total Revenue By Product Category$202,480 $144,577 $354,671 $218,833


     Three Months Ended June 30, Six Months Ended June 30,
      2024  2023  2024  2023
    Mainland China$196,835 $134,767 $348,970 $207,226
    Other Regions 5,645  9,810  5,701  11,607
    Total Revenue By Region$202,480 $144,577 $354,671 $218,833


    ACM RESEARCH, INC.

    Reconciliation of GAAP to Non-GAAP Financial Measures

    As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (“SBC”) from the equivalent GAAP financial line items. In addition, non-GAAP net income attributable to ACM Research, Inc., and basic and diluted earnings per share exclude unrealized gain (loss) on short-term investments. The following tables reconcile gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:

     Three Months Ended June 30,
      2024   2023 
     Actual
    (GAAP)
     SBC Other non-
    operating adjustments
     Adjusted
    (Non-GAAP)
     Actual
    (GAAP)
     SBC Other non-
    operating
    adjustments
     Adjusted
    (Non-GAAP)
     (In thousands)
    Revenue$202,480  $-  $- $202,480  $144,577  $-  $-  $144,577 
    Cost of revenue (105,696)  (792)  -  (104,904)  (75,938)  (125)  -   (75,813)
    Gross profit 96,784   (792)  -  97,576   68,639   (125)  -   68,764 
    Gross margin 47.8%  0.4%  -  48.2%  47.5%  0.1%  -   47.6%
    Operating expenses:               
    Sales and marketing (17,135)  (3,024)  -  (14,111)  (11,439)  (431)  -   (11,008)
    Research and development (25,968)  (4,206)  -  (21,762)  (20,064)  (709)  -   (19,355)
    General and administrative (16,088)  (6,320)  -  (9,768)  (6,706)  (752)  -   (5,954)
    Total operating expenses (59,191)  (13,550)  -  (45,641)  (38,209)  (1,892)  -   (36,317)
    Income (loss) from operations$37,593  $(14,342) $- $51,935  $30,430  $(2,017) $-  $32,447 
    Unrealized gain (loss) on short-term investments 1,031   -   1,031  -   (2,455)  -   (2,455)  - 
    Net income (loss) attributable to ACM Research, Inc.$24,210  $(14,342) $1,031 $37,521  $26,825  $(2,017) $(2,455) $31,297 
    Basic EPS$0.39      $0.60  $0.45      $0.52 
    Diluted EPS$0.35      $0.55  $0.41      $0.48 


     Six Months Ended June 30,
      2024   2023 
     Actual
    (GAAP)
     SBC Other non-
    operating
    adjustments
     Adjusted
    (Non-GAAP)
     Actual
    (GAAP)
     SBC Other non-
    operating
    adjustments
     Adjusted
    (Non-GAAP)
     (In thousands)
    Revenue$354,671  $-  $-  $354,671  $218,833  $-  $-  $218,833 
    Cost of revenue (178,766)  (1,573)  -   (177,193)  (110,208)  (250)  -   (109,958)
    Gross profit 175,905   (1,573)  -   177,478   108,625   (250)  -   108,875 
    Gross margin 49.6%  0.4%  -   50.0%  49.6%  0.1%  -   49.8%
    Operating expenses:               
    Sales and marketing (31,308)  (6,051)  -   (25,257)  (20,776)  (862)  -   (19,914)
    Research and development (49,886)  (8,709)  -   (41,177)  (34,093)  (1,410)  -   (32,683)
    General and administrative (31,886)  (12,578)  -   (19,308)  (14,464)  (1,563)  -   (12,901)
    Total operating expenses (113,080)  (27,338)  -   (85,742)  (69,333)  (3,835)  -   (65,498)
    Income (loss) from operations$62,825  $(28,911) $-  $91,736  $39,292  $(4,085) $-  $43,377 
    Unrealized gain (loss) on short-term investments (1,564)  -   (1,564)  -   (3,109)  -   (3,109)  - 
    Net income (loss) attributable to ACM Research, Inc.$41,643  $(28,911) $(1,564) $72,118  $33,970  $(4,085) $(3,109) $41,164 
    Basic EPS$0.67      $1.17  $0.57      $0.69 
    Diluted EPS$0.61      $1.07  $0.52      $0.63 

    Primary Logo

Share on,